Page 1 of 1
SUNBEAM phase 3 trial for relapsing MS launched
Posted: Wed Jan 21, 2015 6:31 am
by MSUK
Biopharmaceutical company Receptos, Inc. has enrolled the first participant with relapsing multiple sclerosis (RMS) in its SUNBEAM phase 3 trial, which will evaluate the potential therapy RPC1063 in patients who suffer from the disease. The company’s phase 3 RADIANCE trial, also involving RMS patients, had already been initiated, which means that Receptos may be able to finish its clinical development program for multiple sclerosis by 2017, according to the company’s press release......... Read More -
http://www.ms-uk.org/RPC1063
Re: SUNBEAM phase 3 trial for relapsing MS launched
Posted: Wed Jan 21, 2015 8:47 am
by cheerleader
oh, the irony. A sphingosine 1-phosphate 1 and 5 receptor modulator drug trial called "sunbeam."
http://ir.receptos.com/releasedetail.cf ... eid=888647
Meanwhile, the sun's free UV rays have been shown to modulate and calm inflammation and over-active auto-immunity in MS.
http://www.ncbi.nlm.nih.gov/pubmed/24771567
http://www.pnas.org/content/107/14/6418
http://www.jacionline.org/article/S0091-6749(12%2900402-2/abstract
http://ccsviinms.blogspot.com/2014/04/m ... mptom.html
cheer
Re: SUNBEAM phase 3 trial for relapsing MS launched
Posted: Thu Jan 22, 2015 12:16 pm
by 1eye
How is RMS different from RRMS, PPMS, and SPMS? Who decides these monikers?